29.07.2011 • NewsH1 2011Lindesales and profits

Linde H1 Earnings Up

Linde Group's six-month earnings attributable to Linde AG shareholders after adjusting for non-controlling interests advanced to €566 million from €445 million last year. Earnings after tax rose 23.8% to €598 million from €483 million a year ago.

In the first half of 2011, group sales improved 11% to €6.77 billion from €6.10 billion in the comparable period a year ago. After adjusting for exchange rate effects, the increase in sales was 10.3%.

Earnings per share grew by 26.2% to €3.32 from €2.63 a year earlier. On an adjusted basis, after adjusting for the effects of the purchase price allocation from the 2006 BOC acquisition, earnings per share stood at €3.79 compared with €3.15 in 2010.

The company confirmed its outlook and expects to achieve growth in group sales and group operating profit in the 2011 financial year compared with the prior year.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read